A novel anti-PD-L1/IL-8 bispecific antibody BP2402 enhances antitumor immunity and modulates inflammatory signaling in triple-negative breast cancer mice model.
Saved in:
| Title: | A novel anti-PD-L1/IL-8 bispecific antibody BP2402 enhances antitumor immunity and modulates inflammatory signaling in triple-negative breast cancer mice model. |
|---|---|
| Authors: | Song, Liying1 (AUTHOR), Tang, Sumin2 (AUTHOR), Pi, Xuelei3 (AUTHOR), Yan, Yuanyuan3 (AUTHOR), Hu, Chenxi1 (AUTHOR), Liu, Liang1 (AUTHOR), Chen, Hongna3 (AUTHOR), Zhang, Yating3 (AUTHOR), Liu, Shishi3 (AUTHOR), Yu, Dan3 (AUTHOR), Yin, Chengkai3 (AUTHOR), Liu, Tianyan3 (AUTHOR), Li, Xu3 (AUTHOR), Li, Deshan3 (AUTHOR), Wang, Zhenzhong3 (AUTHOR), Zhu, Wei4 (AUTHOR), Hui, Kaiyuan1 (AUTHOR) kyhui1987@163.com, Liu, Zhihang3 (AUTHOR) liu_lucas@126.com, Jiang, Xiaodong1,2 (AUTHOR) jxdpaper@163.com |
| Source: | Journal of Translational Medicine. 10/6/2025, Vol. 23 Issue 1, p1-20. 20p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
